Yvonne J. H. Janssen

Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass.

H. Lamb, F. Roelfsema, M. Stokkel, 2001, The Journal of clinical endocrinology and metabolism.